Established in 2007, StressMarq Biosciences is a bioreagents company producing high quality, cutting edge research products for the life sciences and drug discovery/biopharma markets. StressMarq is a market leader in the development and commercialization of a range of unique fibrilized and oligomeric protein preparations for use in neurodegenerative disease research, including proteins such as alpha synuclein, tau, amyloid beta, SOD1 and TTR. StressMarq’s strategic efforts are focused on expanding the breadth and depth of this product offering to assist researchers studying Alzheimer’s, Parkinson’s, and other neurodegenerative diseases. In addition to a focus on products for neurodegenerative disease research, StressMarq's diverse portfolio of antibodies, proteins, kits and small molecules are utilized across a range of life sciences including neuroscience, cancer research and cell signaling. To aid research worldwide, StressMarq products are available through an extensive network of international distributors in over 45 countries.